Dr. Tavakoli’s Appearance on ‘TV 2’: Innovations in Human Tissue Processing and Allograft Production

Introduction to Iranian Tissue Product Company (Regen Allograft)

Iranian Tissue Product Company is one of the leading knowledge-based enterprises in the field of tissue engineering and the production of allograft and transplantable products in the country. With the goal of providing innovative solutions for patients in need of tissue transplants, the company produces various transplantable tissues, including heart valves, bones, tendons, and regenerative membranes. Utilizing advanced tissue processing and preservation techniques, the company enhances the success rate of transplants by minimizing the risk of rejection.

Key Points from the Interview

In this televised interview, Dr. Amirhossein Tavakoli, CEO of Iranian Tissue Product Company / Regen Allograft, elaborated on innovative processes for manufacturing human tissues and allografts while emphasizing the significance of developing local technologies in this field. He explained that by leveraging human cells and advanced technologies, the company has successfully produced transplantable tissues that are used in reconstructive and transplant surgeries. According to Dr. Tavakoli, these products not only reduce the need for organ donations but also significantly improve patients’ quality of life.

One of the key topics discussed in the interview was the use of cryopreservation techniques, including liquid nitrogen and cryoprotectant solutions, which help maintain cell viability. This advanced technology ensures that processed tissues remain usable long after processing. Additionally, the application of decellularization methods in allograft production has enabled the development of products with minimal risk of rejection, making them safer and more effective for patients.

Challenges and Future Prospects

Dr. Tavakoli also addressed the challenges in sourcing raw materials and developing production infrastructure. He stated that the scarcity of raw materials in recent years has been a major obstacle in the field; however, efforts by the Forensic Medicine Organization and the support of donor families have improved access to donated tissues. Given the increasing demand for these products, the company is actively planning to expand its production lines and enhance its capacity to meet both domestic and international needs.

The Significance of Allograft Products in Modern Medicine

The advanced technologies developed by Iranian Tissue Product Company have provided solutions for many patients without requiring direct organ donations from other individuals. The company’s allograft products, such as processed bone grafts, play a crucial role in spinal reconstructive surgeries, aiding in the restoration of damaged structures. Additionally, for patients with heart conditions, the company’s heart valves serve as effective replacements for damaged heart valves.

 The full video of Dr. Tavakoli’s interview is available on the official website of Iranian Tissue Product Company for those interested in learning more.